236 related articles for article (PubMed ID: 23494279)
21. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2009 Dec; 27(4):182-5. PubMed ID: 19670467
[TBL] [Abstract][Full Text] [Related]
22. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas.
Behdad A; Bailey NG
Surg Pathol Clin; 2016 Mar; 9(1):41-54. PubMed ID: 26940267
[TBL] [Abstract][Full Text] [Related]
24. Aggressive B-cell lymphomas.
Yang W; Listinsky CM
Adv Exp Med Biol; 2005; 563():125-34. PubMed ID: 16433128
[No Abstract] [Full Text] [Related]
25. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.
Turakhia SK; Hill BT; Dufresne SD; Nakashima MO; Cotta CV
Am J Clin Pathol; 2014 Sep; 142(3):339-46. PubMed ID: 25125624
[TBL] [Abstract][Full Text] [Related]
26. Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.
Jaffe ES; Pittaluga S
Hematology Am Soc Hematol Educ Program; 2011; 2011():506-14. PubMed ID: 22160082
[TBL] [Abstract][Full Text] [Related]
27. Challenges in the Diagnosis of Gray Zone Lymphomas.
Parker K; Venkataraman G
Surg Pathol Clin; 2019 Sep; 12(3):709-718. PubMed ID: 31352983
[TBL] [Abstract][Full Text] [Related]
28. Grey zone lymphomas: lymphomas with intermediate features.
Hoeller S; Copie-Bergman C
Adv Hematol; 2012; 2012():460801. PubMed ID: 22548066
[TBL] [Abstract][Full Text] [Related]
29. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
[TBL] [Abstract][Full Text] [Related]
30. Clonal heterogeneity assessed by flow cytometry in B-cell lymphomas arising from germinal centers.
Bellido M; Rubiol E; Ubeda J; Estivill C; Perea G; Rego-Araujo J; Aventín A; Bordes R; Sierra J; Nomdedéu JF
Am J Clin Pathol; 2002 Jun; 117(6):864-70. PubMed ID: 12047137
[TBL] [Abstract][Full Text] [Related]
31. MYC and aggressive B-cell lymphomas.
Slack GW; Gascoyne RD
Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
[TBL] [Abstract][Full Text] [Related]
32. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.
Braziel RM; Arber DA; Slovak ML; Gulley ML; Spier C; Kjeldsberg C; Unger J; Miller TP; Tubbs R; Leith C; Fisher RI; Grogan TM
Blood; 2001 Jun; 97(12):3713-20. PubMed ID: 11389007
[TBL] [Abstract][Full Text] [Related]
33. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.
Perry AM; Crockett D; Dave BJ; Althof P; Winkler L; Smith LM; Aoun P; Chan WC; Fu K; Greiner TC; Bierman P; Gregory Bociek R; Vose JM; Armitage JO; Weisenburger DD
Br J Haematol; 2013 Jul; 162(1):40-9. PubMed ID: 23600716
[TBL] [Abstract][Full Text] [Related]
34. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
[No Abstract] [Full Text] [Related]
35. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
36. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.
Naeini YB; Wu A; O'Malley DP
Ann Diagn Pathol; 2016 Dec; 25():7-14. PubMed ID: 27806850
[TBL] [Abstract][Full Text] [Related]
37. The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.
Menon MP; Pittaluga S; Jaffe ES
Cancer J; 2012; 18(5):411-20. PubMed ID: 23006945
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
[TBL] [Abstract][Full Text] [Related]
39. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
40. Marginal zone cell lymphoma--an update on recent advances.
Maes B; De Wolf-Peeters C
Histopathology; 2002 Feb; 40(2):117-26. PubMed ID: 11952855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
